Endoplasmic reticulum-associated degradation-induced dissociation of class II invariant chain complexes containing a glycosylation-deficient form of p41

被引:3
作者
Sevilla, LM
Comstock, SS
Swier, K
Miller, J
机构
[1] Univ Rochester, Ctr Vaccine Biol & Immunol, Aab Inst, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[3] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA
关键词
D O I
10.4049/jimmunol.173.4.2586
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The quality control system in the secretory pathway-can identify and eliminate misfolded proteins through endoplasmic reticulum-associated degradation (ERAD). ERAD is thought to occur by retrotranslocation through the Sec61 complex into the cytosol and degradation by the proteasome. However, the extent of disassembly of oligomeric proteins and unfolding of polypeptide chains that is required for retrotranslocation is not fully understood. In this report we used a glycosylation mutant of the p41 isoform of invariant chain (Ii) to evaluate the ability of ERAD to discriminate between correctly folded and misfolded subunits in an oligomeric complex. We show that loss of glycosylation at position 239 of p41 does not detectably affect Ii trimerization or association with class 11 but does result in a defect in endoplasmic reticulum export of Ii that ultimately leads to its degradation via the ERAD pathway. Although class 11 associated with the mutated form of p41 is initially retained in the endoplasmic reticulum, it is subsequently released and traffics through the Golgi to the plasma membrane. ERAD-mediated degradation of the mutant p41 is dependent on mannose trimming and inhibition of mannosidase I stabilizes Ii. Interestingly, inhibition of mannosidase I also results in prolonged association between the mutant Ii and class 11, indicating that complex disassembly and release of class 11 is linked to mannosidase-dependent ERAD targeting of the misfolded Ii. These results suggest that the ERAD machinery can induce subunit disassembly, specifically targeting misfolded subunits to degradation and sparing properly folded subunits for reassembly and/or export.
引用
收藏
页码:2586 / 2593
页数:8
相关论文
共 56 条
[1]   INVARIANT CHAIN CAN FUNCTION AS A CHAPERONE PROTEIN FOR CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES [J].
ANDERSON, MS ;
MILLER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2282-2286
[2]   EFFICIENT ENDOSOMAL LOCALIZATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-INVARIANT CHAIN COMPLEXES REQUIRES MULTIMERIZATION OF THE INVARIANT CHAIN TARGETING SEQUENCE [J].
ARNESON, LS ;
MILLER, J .
JOURNAL OF CELL BIOLOGY, 1995, 129 (05) :1217-1228
[3]  
Ashman JB, 1999, J IMMUNOL, V163, P2704
[4]   The C-terminal T peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway [J].
Belbeoc'h, S ;
Massoulié, J ;
Bon, S .
EMBO JOURNAL, 2003, 22 (14) :3536-3545
[5]   Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L [J].
Bevec, T ;
Stoka, V ;
Pungercic, G ;
Dolenc, I ;
Turk, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1331-1338
[6]   MAPPING FUNCTIONAL REGIONS IN THE LUMENAL DOMAIN OF THE CLASS II-ASSOCIATED INVARIANT CHAIN [J].
BIJLMAKERS, MJE ;
BENAROCH, P ;
PLOEGH, HL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :623-629
[7]   Ubiquitin and the control of protein fate in the secretory and endocytic pathways [J].
Bonifacino, JS ;
Weissman, AM .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 :19-57
[8]   MANIPULATING DISULFIDE BOND FORMATION AND PROTEIN FOLDING IN THE ENDOPLASMIC-RETICULUM [J].
BRAAKMAN, I ;
HELENIUS, J ;
HELENIUS, A .
EMBO JOURNAL, 1992, 11 (05) :1717-1722
[9]  
BREMNES B, 1994, J CELL SCI, V107, P2021
[10]   Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi [J].
Caldwell, SR ;
Hill, KJ ;
Cooper, AA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :23296-23303